| 胰高血糖素样肽-1改善非酒精性脂肪性肝病作用机制研究进展* |
| |
| 引用本文： | 信丰智 综述,曹海霞,范建高 审校.胰高血糖素样肽-1改善非酒精性脂肪性肝病作用机制研究进展*[J].实用肝脏病杂志,2018,21(2):313-316. |
| |
| 作者姓名： | 信丰智 综述 曹海霞 范建高 审校 |
| |
| 作者单位： | 200092 上海市 上海交通大学医学院附属新华医院消化内科 |
| |
| 基金项目： | *国家自然科学基金资助项目（编号：81270491） |
| |
| 摘 要： | 近期研究表明,胰高血糖素样肽-1受体激动剂可从改善肝细胞脂质代谢、抑制炎症反应、调节细胞自噬等多个环节减轻非酒精性脂肪性肝病（NAFLD）患者肝脏脂质沉积,改善组织学损伤,有望成为治疗NAFLD药物的新选择。
|
| 关 键 词： | 非酒精性脂肪性肝病 胰高血糖素样肽-1 作用机制 |
| 收稿时间： | 2017-01-10 |
Glucagon-like peptide-1 in melioration of non-alcoholic fatty liver disease |
| |
| Xin Fengzhi,Cao Haixia,Fan Jiangao.Glucagon-like peptide-1 in melioration of non-alcoholic fatty liver disease[J].Journal of Clinical Hepatology,2018,21(2):313-316. |
| |
| Authors: | Xin Fengzhi Cao Haixia Fan Jiangao |
| |
| Affiliation: | Department of Gastroenterology,Xinhua Hospital,JiaoTong University School of Medicine,Shanghai 200092,China |
| |
| Abstract: | Glucagon-like peptide-1 receptor agonists could meliorate hepatic lipid deposition and histological damage by regulating lipid metabolism,inflammation and autophagy in pathogenesis of non-alcoholic fatty liver disease （NAFLD）,which may serve as a new option for treatment of patients with NAFLD. |
| |
| Keywords: | Non-alcoholic fatty liver disease Glucagon-like peptide 1 Pathogenesis |
|
| 点击此处可从《实用肝脏病杂志》浏览原始摘要信息 |
|
点击此处可从《实用肝脏病杂志》下载全文 |
